PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.09%
Revenue growth 1.25-1.5x META's 12.29%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
18.71%
Gross profit growth above 1.5x META's 12.33%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-97.90%
Negative EBIT growth while META is at 10.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.90%
Negative operating income growth while META is at 16.44%. Joel Greenblatt would press for urgent turnaround measures.
-34.25%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-34.62%
Negative EPS growth while META is at 10.47%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-34.62%
Negative diluted EPS growth while META is at 11.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.22%
OCF growth above 1.5x META's 6.39%. David Dodd would confirm a clear edge in underlying cash generation.
139.87%
Positive FCF growth while META is negative. John Neff would see a strong competitive edge in net cash generation.
424.75%
10Y revenue/share CAGR under 50% of META's 1223.16%. Michael Burry would suspect a lasting competitive disadvantage.
424.75%
5Y revenue/share CAGR above 1.5x META's 190.49%. David Dodd would look for consistent product or market expansions fueling outperformance.
424.75%
3Y revenue/share CAGR above 1.5x META's 77.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.81%
Below 50% of META's 2770.56%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
47.81%
Below 50% of META's 304.58%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
47.81%
Below 50% of META's 194.47%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.37%
AR growth well above META's 14.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
117.51%
Asset growth above 1.5x META's 5.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
154.57%
BV/share growth above 1.5x META's 5.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-26.57%
We’re deleveraging while META stands at 0.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
25.45%
R&D growth drastically higher vs. META's 6.52%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.92%
SG&A growth well above META's 12.01%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.